GHK-Cu
Copper-binding tripeptide studied in regenerative biology.
Evidence Level
Moderate
Research Type
/ System Mapping
Where this compound appears in research pathways
Research-only note: This mapping is educational and does not represent a treatment protocol.
/ 01
Overview
Copper-binding tripeptide studied in regenerative biology.
/ 02
Mechanism of Action
Studied for collagen synthesis modulation, gene expression effects, and antioxidant signaling.
/ 03
Research Applications
Skin remodeling, wound healing, collagen and copper transport.
Studied for, research explores, preclinical models suggest, clinical studies have investigated.
/ 04
Studied Research Contexts
/ 05
Studied Research Dosing Ranges
Limited public data on dosing ranges across research models.
/ 06
Potential Adverse Effects Reported in Research
Adverse effect data is limited. Many compounds in this database lack human safety profiles.
/ 07
Mechanism Deep Dive
GHK-Cu is a copper-binding tripeptide (Gly-His-Lys) studied for influence on collagen and glycosaminoglycan synthesis, modulation of matrix metalloproteinase activity, and gene expression patterns associated with extracellular matrix remodeling and skin biology.
/ 08
Pathway Role
Operates within the extracellular matrix remodeling and skin repair pathway, at the interface of collagen synthesis, MMP regulation, and copper-dependent enzymatic activity.
/ 09
Biological Targets
/ 10
Research Applications
- Skin repair and dermatology research
- Wound healing models
- Hair follicle biology (preclinical)
- Extracellular matrix remodeling studies
/ 11
Evidence Summary
Skin biology and wound-repair literature is moderately developed, including in vitro, animal, and some human cosmetic studies.
Evidence Level Rationale
Rated moderate because skin and wound-related mechanisms are reasonably documented across multiple model systems.
/ 12
Research Observation Timeline
Early Signal Window
Gene expression and cell-level changes within hours to days in vitro
Primary Study Window
Weeks to months for skin and wound remodeling endpoints
Endpoint Type
Histological, biomarker, and visual skin endpoints
Evidence Strength
Moderate for skin and wound contexts
/ 13
Safety & Unknowns
Topical research use has a longer track record than systemic use. Systemic dosing and long-term outcomes are not well-characterized in controlled studies.
/ 14
Research Limitations
Many cosmetic studies are small or industry-funded. Systemic application data is more limited than topical data.
/ 15
References
References are being curated from peer-reviewed literature.
/ 07
Evidence Score
Overall Research Confidence
Moderate
Reflects breadth of mechanism, study type, and reproducibility across research literature.
/ 08
Related Peptides
KPV
Tripeptide fragment of α-MSH studied for inflammatory modulation.
BPC-157
Pentadecapeptide studied for tissue protection and repair models.
TB-500
Thymosin Beta-4 fragment
Synthetic fragment studied for cell migration and tissue remodeling.
Appears in pathways
For research and educational purposes only.
Not medical advice. Not intended to diagnose, treat, cure, or prevent disease. Compounds discussed may not be approved for human use. Any dosing information shown describes ranges studied in research settings — never a recommendation.